International activities: panellists needed for German biomanufacturing in Australia and Israel
The Federal Ministry of Economics and Technology’s export initiative, Health Made in Germany, supports German life science companies in exporting their goods and services. The Working Group on Medical Biotechnology has been set up as part of this export initiative with the sector association, BIO Deutschland, as one of its members. The working group is currently focusing on German biomanufacturing and recently compiled the “German Biomanufacturing Guide”, which is available at www.biodeutschland.org/biothek.html.
As part of the working group’s activities, two further marketing events for German biomanufacturing companies are planned:
Australia: Ausbiotech 2011, www.ausbiotech2011.com.au/, Australia’s largest biotechnology congress, will take place from 15 to 19 October 2011 in Adelaide. The working group will hold a panel discussion as part of the official congress programme. The slot has been confirmed for 11.00 to 11.45 (or 12.30 if preferred) on 18 October 2011. Representatives from German biotech companies are still needed for the panel. Ausbiotech and its partnering event have a high number of visitors. The event organisation is very efficient. Australia’s biotech industry has witnessed strong growth in recent years and the country currently has some 450 biotech companies. However, its biomanufacturing sector is not as strong, which means that there is an attractive market for German biomanufacturing companies.
Israel: the working group already held an event during ILSI-Biomed on 22 May that proved the importance the Israeli biomanufacturing market. A German biomanufacturing delegation trip, including partnering and a panel discussion, is planned as a follow-up event on 22 and 23 November 2011. After arriving on 22 November, there will be a visit to the Bio Negev cluster during the early evening (http://bionegev.org/en/index.html) which will include a meeting with local companies and cluster representatives. Previously organised one-to-one meetings and the panel discussion will take place in Tel Aviv the following day. Company profiles will be produced in advance. All relevant biotech companies in Israel will be contacted in writing and there will also be telephone follow-up. €200 will be charged as a fee for the organisation of the event.
If you have any questions, please contact Tilo Mandry, Senior Manager, Health Made in Germany export initiative, Germany Trade & Invest GmbH (tel.: +49-(0)-30 200 099-605, e-mail: firstname.lastname@example.org ).